PhRMA (@PhRMA) header
PhRMA (@PhRMA) profile picture

Representing America’s biopharma & biotech companies. Shaping policy so science thrives & patients benefit. 📱Text JOIN to 254506

Washington, DC
Joined February 2010
Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)Photo by PhRMA (@PhRMA)
Pinned Tweet
Patients are counting on the next breakthrough and you can help make it happen when you text JOIN to 254506 🔬✨
1,308
When someone receives a life-altering diagnosis, they and their loved ones want to know one thing: is there a safe and effective treatment? Global partnerships help bring breakthrough medicines to American patients, but a proposed rule could make that harder. Learn what’s at stake: ow.ly/TZLV5108awE
275
New president and CEO, Eric Cantor, comes to PhRMA with a clear focus: finding common ground while ensuring new treatments and cures get to the patients who are counting on them. In a new interview with @washingtonsun, he discusses how his experience in Congress and on Wall Street will shape his approach, why government price setting threatens future innovation and what’s at stake for patients if investment in U.S. research declines. Read the full interview: washingtonsun.com/congress/e…
4
5
1,178
Parents like Colette want to spend their energy taking care of their kids, not fighting to figure out how to get a medication. AmericasMedicines.com makes it easier to access medicine.
448
China made biopharma a national strategic priority and is now producing some of the world's most promising science. But more science in China doesn’t mean less science in America. U.S. Phase 1 clinical trials have increased and U.S. biotech remains a magnet for capital investment. Keep reading: ow.ly/wjrp5107vBE
1
505
Strong IP protections have helped fuel 900+ new medicines since 2000. Don’t undermine what’s working. Protect innovation and tackle the barriers patients face today, including insurer and PBM practices that can restrict access to lower-cost medicines.
557
PhRMA retweeted
The loss of America's measles elimination status is a sobering and preventable public health setback. We have the science and tools to eliminate measles again. Now we need to restore confidence in vaccination and protect our communities. Our statement: phrma.org/resources/phrma-st…
3
2
2
361
Your doctor prescribed a treatment. But your PBM and insurer keep adding hurdles while you keep waiting for the care your doctors prescribed. It’s time to hold PBMs and insurers accountable. Learn more at PhRMA.org/AskYourPBM
432
⏱️ 70% of commercially insured patients were initially denied coverage for at least one newly prescribed brand medicine in 2024. PBMs and insurers don’t just delay care, they deny it. It’s time to hold PBMs and insurers accountable. Learn more at PhRMA.org/PBMs
2
2
617
Just 36 months after engineering cells in a lab, a mother of three with stage 4 melanoma was dosed with a therapy developed in Houston. She’s alive today because of biopharmaceutical innovation. At @axios Live’s Houston event, Rice Biotech Launchpad’s Paul Wotton shared the very real patient impact of a strong innovation ecosystem. ow.ly/itXP5106AQI
3
824
Having insurance should mean getting the medicines you need, but in 2024, 70% of commercially insured patients were initially denied coverage on new meds. You shouldn’t have to jump through hoops to get your treatment, and you deserve answers about why it’s happening. Learn more at PhRMA.org/AskYourPBM
2
619
NEW: Latest research adds to decades of evidence supporting hepatitis B vaccination at birth. The study also highlights the consequences of changing this practice — warning that chronic infections could increase by 83%. ow.ly/VWOK5106wpy
1
1
612
It’s one thing to discover cures, but we also need to be able to manufacture them so patients can benefit. Houston has the unique capability to do both. Steve Kean, from @GHPartnership, discussed the winning combination at @axios Live’s Beyond the Breakthrough event. ow.ly/fwas5106vRO
1
2
655
📣 PDUFA is critical to patients and it’s important for Congress to reauthorize it. PDUFA VIII will strengthen America's competitive edge to ensure America’s patients continue to have the fastest access to lifesaving medicines. Learn more: ow.ly/FCyk51069ib
614
Retired Air Force Lt. Col. Ken served his country for years. In 2019, he faced a new fight when he was diagnosed with early stage prostate cancer. Thanks to medical innovation, Ken won his battle against cancer and maintained his quality of life. Learn more at AmericaCures.com
1
622
What does a place like Houston have to do with global biopharmaceutical competition with China? Rice Biotech Launchpad’s Paul Wotton lays it out. Watch the @axios Live clip from the Houston event 🔊 ow.ly/Xh0E5105tkJ
601
$142 BILLION. $142,000,000,000. That’s how much hospitals, clinics and their for-profit partners pocketed from 340B medicine markups in 2025. Learn more at PhRMA.org/340B.
2
3
607
Our mandate is to advance and protect the American biopharmaceutical industry while championing policies that help patients access the medicines they need. To accomplish these goals, we need to have a strong, decisive leadership team. We're pleased to announce two important additions to PhRMA's leadership team. Kristi Way has joined PhRMA as Senior Executive Vice President, Head of Strategy and Operations. Kristi brings decades of leadership experience across government, business and strategic operations, most recently at Moelis & Company. She previously served as Chief of Staff and Senior Advisor to Eric Cantor during his tenure in Congress. Michael Woody has been promoted to Executive Vice President, Federal Advocacy. Mike brings more than 20 years of experience in federal health policy, including ​as a senior health policy advisor to Former Senator Tom Harkin (D-IA) on the Senate HELP Committee. Since returning to PhRMA in 2022, he has played a key role in strengthening our bipartisan engagement on Capitol Hill and advancing policies that support patients and American innovation. ​Together, Mike and Kristi will play important roles in advancing PhRMA’s mission providing patients access to life saving and life changing medicines while in pursuit of more American innovation. Congratulations Kristi and Mike!
2
1
9
1,776
From efficient clinical trials to training the workforce for companies like @EliLillyandCo and @bmsnews, Houston has all the elements for biopharmaceutical innovation. Watch to learn more 🎥
2
620
American innovation created continuous glucose monitors, a breakthrough that made diabetes manageable for kids and adults. For moms like Flora, who know what it’s like to have a kid with Type 1 diabetes, they’re waiting for the next breakthrough – a cure for diabetes. It’s up to Washington to make sure we keep our biopharmaceutical edge.
2
3
567